Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Asian Institute Of Oncology
Location
People
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
Network
T. Score
Peers
Registered Details

Get this company's details upto March 2024. FREE access. Sign up now!

ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED

All Companies ›

Maharashtra ›

Health and Social Work ›

Active

Updated: 27 Dec 2023

Asian Institute Of Oncology Private Limited, is an unlisted private company incorporated on 01 January, 2003. It is classified as a private limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 25.00 cr and the total paid-up capital is INR 15.87 cr.

Asian Institute Of Oncology's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2022. It's book networth has decreased by 4.3%.

Subscription Plans

Industry and products

Health and Social Work

Pancreatic Cancer, Women Smoke Cervical Cancer, Cervical Cancer Month, Symptoms Testicular Cancer Treatment., Non Smoker Cancer, Multiple Myeloma Cancer, Robotic Surgery For Cancer

Company size

Auth Capital

₹ 25.0 Cr

Paidup Capital

₹ 15.9 Cr

Revenue

₹ 25-50 cr

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue

-11.16%

₹ GET PRO

EBITDA

₹ GET PRO

Net Profit

₹ GET PRO

Networth

59.91%

₹ GET PRO

Borrowings

-31.96%

₹ GET PRO

Assets

-27.69%

₹ GET PRO

Gross Margin

-1.34

GET PRO %

Operating Margin

-21.37

GET PRO %

Net Profit Margin

-21.98

GET PRO %

Return on Equity

-52.4

GET PRO %

ROCE

31.05

GET PRO %

Debt to Equity

-10.97

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

Buy credits

View subscriptions

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (4)

State	Type	Address

Locations on Map

People

Designation	Name	DIN/PAN	Tenure
Director	Ramakant Krishnaji Deshpande Shareholder	00374907	13 years
Director	Jagdeesh Narhar Kulkarni Shareholder	01297932	22 years
Director	Sanjay Harishankardhar Sharma Shareholder	07063286	10 years
Additional Director	Varun Deshpande Ramakant	07868594	3 years
Director	Raghvendra Jagdeesh Kulkarni	09619429	3 years
Kmp	Divyaprakash Rajendra Dubey	<HIDDEN>	6 years

Financial Highlights

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	11.8	15.9	15.9	15.9	34.0
Reserves	-6.7	-6.7	-7.7	-14.5	56.5
Borrowings +	72.2	71.4	72.3	106.8	83.2
Long term borrowings	69.4	66.6	64.8	10.6	43.4
Short term borrowings	2.8	4.8	7.5	96.3	39.8
Trade payables +	16.9	14.2	20.8	20.2	17.8
Days payable	518.0	577.0	839.0	821.0	768.0
Other liabilities +	31.4	29.4	41.6	28.7	25.5
Other non-current liabilities	0.6	0.9	1.4	1.2	1.0
Other current liabilities	13.9	14.3	19.5	7.3	6.7
Total liabilities	108.7	110.0	122.0	136.9	199.2
Fixed Assets +	13.1	9.7	8.9	23.0	130.1
Tangible assets	11.8	9.5	8.6	9.2	37.2
CWIP	0.9	-	-	13.7	-
Intangible assets	0.4	0.2	0.2	-	92.9
LT loans and advances	87.7	94.2	105.8	11.1	1.6
Other non-current assets	-	-	-	98.9	52.4
Current assets +	7.9	6.1	7.3	3.9	15.1
Inventories	3.3	1.8	1.4	1.0	0.9
Trade receivables	3.0	2.2	3.4	0.2	1.5
Cash and cash equivalents	0.9	0.2	2.2	2.0	10.0
ST loans and advances	0.7	0.6	0.3	0.6	2.4
Other current assets	-	1.3	-	0.1	0.2
Total assets	108.7	110.0	122.0	136.9	199.2

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	10.9	14.43	13.01	11.59	17.07
Reserves	-6.21	-6.12	-6.32	-10.61	28.37
Borrowings +	66.4	64.96	59.23	78.04	41.76
Long term borrowings	63.79	60.6	53.1	7.73	21.79
Short term borrowings	2.61	4.36	6.13	70.3	19.97
Trade payables	15.53	12.94	17.01	14.73	8.92
Other liabilities +	28.91	26.73	34.08	20.98	12.8
Other non-current liabilities	0.59	0.82	1.12	0.9	0.52
Other current liabilities	12.79	12.96	15.95	5.36	3.35
Total liabilities
Fixed Assets +	12.09	8.8	7.25	16.82	65.33
Tangible assets	10.9	8.61	7.04	6.75	18.66
CWIP	0.85	0.0	0.07	10.02	0.0
Intangible assets	0.34	0.2	0.14	0.04	46.67
LT loans and advances	80.66	85.63	86.74	8.09	0.79
Other non-current assets	0.0	0.0	0.0	72.26	26.29
Current assets +	7.26	5.57	6.0	2.82	7.59
Inventories	2.99	1.61	1.15	0.73	0.48
Trade receivables	2.73	2.01	2.78	0.15	0.75
Cash and cash equivalents	0.86	0.18	1.77	1.45	5.03
ST loans and advances	0.68	0.57	0.26	0.42	1.22
Other current assets	0.0	1.2	0.04	0.08	0.11
Total assets

Total assets

Charges on assets

Bank wise

Charges

HDFC Bank Limited

No. of Loans: 2

Total Amount : 40.2 cr

Charge Holder	Amount	Date of creation/modification
HDFC Bank Limited	40.0 cr	09 Dec, 2022
HDFC Bank Limited	0.2 cr	03 Sep, 2022

Charges

HDFC Bank Limited

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
TANNA BUILDERS PRIVATE LIMITED	Active	6.9 Cr	1	Maharashtra
ASIAN ONCOLOGY PRIVATE LIMITED	Active	2.0 L	2	Maharashtra
KARNATAKA LEASING AND COMMERCIAL CORPORATION LIMITED	Active	1.2 Cr	2	Karnataka
TRIUMPH ESTATES PRIVATE LIMITED	Active	4.3 Cr	2	Maharashtra
GTOS TECHNOLOGIES PRIVATE LIMITED	Active	1.0 L	1	Tamil Nadu
ASIAN CANCER FOUNDATION	Active	39.1 L	3	Maharashtra
TRIUMPH CANCER INSTITUTE PRIVATE LIMITED	Active	5.0 L	2	Maharashtra
TRIUMPH HOSPITALS PRIVATE LIMITED	Active	7.0 L	1	Maharashtra
ALTERNATIVE PROTEIN SOLUTIONS PRIVATE LIMITED	Active	1.0 L	1	Maharashtra
GREEN PROTEIN FOUNDATION	Active	0.0	1	Maharashtra
HOPSCOTCH VENTURES PRIVATE LIMITED	Active	1.0 L	1	Maharashtra

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
ASIAN ONCOLOGY PRIVATE LIMITED	Maharashtra	2016	₹ 2.0 L
TRIUMPH CANCER INSTITUTE PRIVATE LIMITED	Maharashtra	2018	₹ 5.0 L
MEDIRAD TECH INDIA LIMITED	Delhi	1998	₹ 11.9 Cr

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Peers / Similar Companies

Cmr Surgical India Private Limited Goa

Peers

Cmr Surgical India Private Limited

Goa

Registered Details

CIN

U85110MH2003PTC138491

PAN

AAECA1363P

Incorporation

2003, 22.4 years

Company Email

d.dubey@acicancer.com

Paid up Capital

₹ 15.9 Cr

Authorised Capital

₹ 25.0 Cr

AGM

Sep 2023

Type

Private

Non-government Company

FAQ - ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED

What is the incorporation date of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED?

The incorporation date of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED is 01 January, 2003

What is the authorized share capital of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED?

The authorized share capital of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED is INR ₹ 25.0 Cr.

What is the paid-up capital of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED?

The paid-up capital of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED is INR ₹ 15.9 Cr.

What is the registered address of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED?

The registered address of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED is 93/95, Cumbala Hill Hospital August Kranti Marg, Kemps Corner Mumbai Mumbai City Maharashtra - 400036

What is the CIN number of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED?

The CIN number of ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED is U85110MH2003PTC138491.

Smart Suggestions

Top Blog Post

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

ASIAN INSTITUTE OF ONCOLOGY PRIVATE LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Buy Report or Plans

Dashboards

Company dashboard

Buy credits

View subscriptions

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Choose number of credits to buy

₹ 449 + GST

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

People

Financial Highlights

Margins

Balance Sheet

Total assets

Charges on assets

Charges

Company Network